Delaware coverage

Timber Pharmaceuticals: $14.35M Credit-Bid Sale to LEO Pharma and Liquidating Plan

Timber Pharmaceuticals filed chapter 11 in Delaware on Nov. 17, 2023. LEO Pharma credit-bid $14.35M for its TMB-001 dermatology program after a failed merger. The liquidating plan projected 11.1%–44.3% recovery for unsecured creditors; final decree entered Jan. 29, 2025.

PrenegotiatedHealthcare & life sciences

Week of June 1, 2026

Vintage Wine Estates: $140M Sale and Liquidating Plan

Rokstad Holdings: CAD$20M Canadian Sale in Cross-Border Chapter 15

HDC Holdings II (Dirt Cheap): $36.5M ABL Freefall and Chapter 7

Avante Health Solutions: $72.5M Credit-Bid Sale Ends in Chapter 7

Pivotal Post: $22M Insider Credit-Bid Sale and Dismissal

Timber Pharmaceuticals: $14.35M Credit-Bid Sale to LEO Pharma and Liquidating Plan

CTN Holdings: $20M Credit Bid Sale and Chapter 7 Conversion

Crystallex International: $5.9B PDVH Share Sale and Chapter 15 Enforcement

Village Roadshow: Liquidation Plan Confirmed with $57M Warner Bros. Settlement

Navidea Biopharmaceuticals: $11.95M Sale and Subchapter V Liquidation Plan Confirmed

Impac Mortgage: Court Confirms $23.95M Hildene Debt-for-Equity Plan

Week of May 18, 2026

Pinstripes Holdings: From $520M SPAC Debut to Chapter 7 in Under Two Years